Human platelet antigen typing of neonatal alloimmune thrombocytopenia patients using whole genome amplified DNA and a 5-nuclease assay

Transfusion

Volumn 49, Issue 5, 2009, Pages 953-958

  Navarrete, Cristina V ^a   Lemnrau, Alina G ^b   Cardoso, Sandra ^b   Creary, Lisa E ^b   Brown, Colin ^b   Miretti, Marcos ^b   Girdlestone, John ^b  

^a International Union of Societies for Biomaterials Science and Engineering   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEASE; THROMBOCYTE ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TEMPLATE; GENE AMPLIFICATION; GENOTYPE; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

ANTIGENS, HUMAN PLATELET; DNA PRIMERS; GENOME, HUMAN; GENOTYPE; HUMANS; INFANT, NEWBORN; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 65349097980     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02064.x     Document Type: Article

References (17)

1. Althaus J, Blakemore KJ. Fetomaternal alloimmune thrombocytopenia: the questions that still remain. J Maternal Fetal Neonatal Med 2007 20 : 633 7.
2. Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia. Orphanet J Rare Diseases 2006 1 : 39.
3. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomäki R, de Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. Nomenclature of human platelet antigens (HPA). Vox Sang 2003 85 : 240 5.
4. Kaplan C. Neonatal alloimmune thrombocytopenia: where do we stand? ISBT Sci Ser 2007 2 : 85 8.
5. Ouwehand WH, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000 82 : 173 5.
6. Newman P, Valentin N. Human platelet alloantigens: recent findings, new perspectives. Thromb Haemost 1995 74 : 234 9.
7. Hosono S, Faruqi FA, Dean FB, Du Y, Sun Z, Wu X, Du J, Kingsmore SF, Egholm M, Lasken RS. Unbiased whole-genome amplification directly from clinical samples. Genome Res 2003 13 : 954 64.
8. Holbrook JF, Stabley D, Sol-Church K. Exploring whole genome amplification as a DNA recovery tool for molecular genetic studies. J Biomol Tech 2005 16 : 125 33.
9. Bergen AW, Qi Y, Haque KA, Welch RA, Chanock SJ. Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance. BMC Biotechnol 2005 5 : 24 35.
10. Ficko T, Galvani V, Rupreht T, Dovc T, Rozman P. Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSp method. Transfus Med 2004 14 : 425 32.
11. Creary LE, Girdlestone J, Zamora J, Brown J, Navarrete CV. Molecular typing of HLA genes using whole genome amplified DNA. Transfusion 2009 49 : 57 63.
12. Bugert P, McBride S, Smith G, Dugrillon A, Kluter H, Ouwehand WH, Metcalfe P. Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45 : 654 9.
13. Monni G, Ibba RM, Olla G, Rosatelli C, Cao A. Prenatal diagnosis of beta-thalassaemia by second-trimester chorionic villus sampling. Prenat Diagn 1988 8 : 447 51.
14. Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn 2006 26 : 925 30.
15. Seeeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 2004 191 : 608 16.
16. Frederickson RM, Wang H, Surh LC. Some caveats in PCR-based prenatal diagnosis on direct amniotic fluid versus cultured amniocytes. Prenat Diagn 1999 19 : 113 17.
17. Singh KK, Spector SA. Fidelity of whole-genome amplification of blood spot DNA for HLA typing and SNP analyses. Clin Genet 2007 72 : 156 9.